University of Kentucky third-year medical students praised the work of several dozen residents and fellows for demonstrating teaching excellence during the students’ first two surgery rotations. Those residents were given official recognition before their peers during surgery Grand Rounds early Wednesday morning as part of a new program for the 2019-20 academic year.

University of Kentucky radiology resident Dr. Leanna Lin likes to use her strength for good causes.

This Saturday, Lin has organized an event called Deadlifts Against Domestic Violence, a powerlifting-style deadlift competition hosted by The Moco Gym in Mount Sterling, Ky. All the money received with sales and registration fees will benefit GreenHouse17, an advocacy agency committed to ending intimate partner abuse in families and the community.

Flanked by national leaders in the fight to reduce deaths from opioid use – including Senate Majority Leader Mitch McConnell and Health and Human Services Secretary Alex M. Azar – the University of Kentucky Monday officially launched the HEALing (Helping End Addiction Long-term) Communities Study – Kentucky.

UK HealthCare has 154 physicians practicing medicine with University of Kentucky Albert B. Chandler Hospital, Kentucky Children's Hospital and UK Good Samaritan Hospital who appear on the Best Doctors in America List for 2019-20 — more than any other hospital in Kentucky. 

In September the Department had ten new publications listed in PubMed.

1: Zhang J, Liu Y, Jiang K, Jia J. Hedgehog signaling promotes lipolysis in adipose tissue through directly regulating Bmm/ATGL lipase. Dev Biol. 2019 Sep 21. pii: S0012-1606(19)30338-0. doi: 10.1016/j.ydbio.2019.09.009. [Epub ahead of print] PubMed PMID: 31550483.

LOUISVILLE, Ky. and TAMPA, Fla. (Oct. 4, 2019) – A pilot program in eastern Kentucky designed to remove barriers to healthcare services has shown promising results, including a reduction in emergency room (ER) visits and hospital admissions among a group of nearly 2,000 rural Kentuckians.

The University of Kentucky Sanders-Brown Center on Aging has received a five-year, $2.8 million grant to underwrite preclinical efficacy studies of a potential new treatment for dementia. 

The drug candidate, called MW150, targets dysregulated brain inflammation driven by a stress-activated protein called p38aMAPK. The research is novel in that it is exploring efficacy in treating more than one form of dementia at the same time. 

Alzheimer's disease wreaks emotional havoc on patients, who are robbed of their memories, their dignity, and their lives. It’s financially devastating as well: care for Alzheimer's patients is predicted to top $1 trillion by the time children born today are having children of their own.